{"id":1630,"date":"2004-05-01T12:02:00","date_gmt":"2004-05-01T10:02:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/whi-studie-jetzt-auch-im-oestrogen-ohne-gestagen-arm-beendet"},"modified":"2004-05-01T12:02:00","modified_gmt":"2004-05-01T10:02:00","slug":"whi-studie-jetzt-auch-im-oestrogen-ohne-gestagen-arm-beendet","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/whi-studie-jetzt-auch-im-oestrogen-ohne-gestagen-arm-beendet","title":{"rendered":"WHI-Studie jetzt auch im \u00d6strogen-ohne-Gestagen-Arm beendet"},"content":{"rendered":"<p>Wir haben mehrfach \u00fcber die Ergebnisse der im Jahr 2002 nach im Mittel 5,2 Jahren Laufzeit abgebrochenen WHI (Women\u2019s Health Initiative)-Studie Teil 1 (\u00d6strogen plus Gestagen versus Plazebo bei postmenopausalen Frauen) berichtet (1-3). Die Studie war begonnen worden, um die Frage zu pr\u00fcfen, ob die sog. Hormonersatz-Therapie (HRT) vor Herz-\/Kreislauferkrankungen sch\u00fctzt. Dies hatten Ergebnisse nicht-randomisierter [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wir haben mehrfach \u00fcber die Ergebnisse der im Jahr 2002 nach im Mittel 5,2 Jahren Laufzeit abgebrochenen WHI (Women\u2019s Health Initiative)-Studie Teil 1 (\u00d6strogen plus Gestagen versus Plazebo bei postmenopausalen Frauen) berichtet (1-3). Die Studie war begonnen worden, um die Frage zu pr\u00fcfen, ob die sog. Hormonersatz-Therapie (HRT) vor Herz-\/Kreislauferkrankungen sch\u00fctzt. Dies hatten Ergebnisse nicht-randomisierter [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[60,61,146,2891,71,68,430,498,69,149,65,2906,56,54,51,55,1088],"class_list":["post-1630","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-apoplektischer-insult","tag-beinvenenthrombose","tag-brustkrebs","tag-frakturen","tag-herzinfarkt","tag-hirninfarkt","tag-kolonkarzinom","tag-koronare-herzkrankheit","tag-lungenembolie","tag-mammakarzinom","tag-myokardinfarkt","tag-schenkelhalsfrakturen","tag-schlaganfall","tag-thromboembolie","tag-thrombose","tag-venenthrombose","tag-whi-studie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1630"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1630\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}